{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:50:04Z","timestamp":1772088604553,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12020-018-1793-z","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T04:02:49Z","timestamp":1540526569000},"page":"233-238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The prescription rates of glucagon for hypoglycemia by pediatricians and physicians are low in Japan"],"prefix":"10.1007","volume":"64","author":[{"given":"Masaaki","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-4142","authenticated-orcid":false,"given":"Hiroyuki","family":"Awano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehito","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"1793_CR1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.13994","volume":"318","author":"B Karges","year":"2017","unstructured":"B. Karges, A. Schwandt, B. Heidtmann, O. Kordonouri, E. Binder, U. Schierloh, C. Boettcher, T. Kapellen, J. Rosenbauer, R.W. Holl, Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA 318, 1358\u20131366 (2017)","journal-title":"JAMA"},{"key":"1793_CR2","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1089\/dia.2012.0290","volume":"15","author":"T Murata","year":"2013","unstructured":"T. Murata, K. Okazaki, K. Yanagisawa, K. Yamada, N. Kuribayashi, Y. Totsuka, T. Hiyoshi, M. Naka, M. Sugimoto, Y. Aoki, M. Waki, M. Furuya, H. Kitaoka, M. Oishi, I. Shimizu, H. Miyaoka, T. Yamamoto, K. Yamada, N. Sakane, Glucagon underutilized among type 1 diabetes mellitus patients in Japan. Diabetes Technol. Ther. 15, 748\u2013750 (2013)","journal-title":"Diabetes Technol. Ther."},{"key":"1793_CR3","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1542\/peds.2004-1439","volume":"115","author":"R Alemzadeh","year":"2005","unstructured":"R. Alemzadeh, T. Berhe, D.T. Wyatt, Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 115, 1320\u20131324 (2005)","journal-title":"Pediatrics"},{"key":"1793_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/ped.12521","volume":"56","author":"T Urakami","year":"2014","unstructured":"T. Urakami, M. Habu, J. Suzuki, Diabetic ketoacidosis and severe hypoglycemia in management of type 1 diabetes during 2003-2013. Pediatr. Int. 56, 940 (2014)","journal-title":"Pediatr. Int."},{"key":"1793_CR5","unstructured":"M. Namba, T. Iwakura, R. Nishimura, K. Akazawa, M. Matsuhisa, Y. Atsumi, J. Satoh, T. Yamauchi; Japan Diabetes Society (JDS) Committee for Surveys on Severe Hypoglycemia. The current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus: a report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society. J Diabetes Investig. 9, 642\u2013656 (2018)"},{"key":"1793_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/pedi.12174","volume":"15","author":"TT Ly","year":"2014","unstructured":"T.T. Ly, D.M. Maahs, A. Rewers, D. Dunger, A. Oduwole, T.W. Jones, International Society for Pediatric and Adolescent Diabetes, ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr. Diabetes 15, 180\u2013192 (2014).","journal-title":"Pediatr. Diabetes"},{"key":"1793_CR7","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1210\/jc.2012-4127","volume":"98","author":"ER Seaquist","year":"2013","unstructured":"E.R. Seaquist, J. Anderson, B. Childs, P. Cryer, S. Dagogo-Jack, L. Fish, S.R. Heller, H. Rodriguez, J. Rosenzweig, R. Vigersky, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J. Clin. Endocrinol. Metab. 98, 1845\u20131859 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1793_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/M17-1259","volume":"167","author":"JJ Chamberlain","year":"2017","unstructured":"J.J. Chamberlain, R.R. Kalyani, S. Leal, A.S. Rhinehart, J.H. Shubrook, N. Skolnik, W.H. Herman, Treatment of type 1 diabetes: synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann. Intern. Med. 167, 493\u2013498 (2017)","journal-title":"Ann. Intern. Med."},{"key":"1793_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pdi.138","volume":"18","author":"G Harris","year":"2001","unstructured":"G. Harris, A. Diment, M. Sulway, M. Wilkinson, Glucagon administration - underevaluated and undertaught. Pract. Diabetes Int. 18, 22\u201325 (2001)","journal-title":"Pract. Diabetes Int."},{"key":"1793_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/0145721707312400","volume":"34","author":"T Pearson","year":"2008","unstructured":"T. Pearson, Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized. Diabetes Educ. 34, 128\u2013134 (2008)","journal-title":"Diabetes Educ."},{"key":"1793_CR11","first-page":"1748","volume":"112","author":"W Clarke","year":"2008","unstructured":"W. Clarke, T. Jones, A. Rewers, D. Dunger, G.J. Klingensmithe, International Society for Pediatric and Adolescent Diabetes clinical practice consensus guidelines 2006-2008 (Japanese translation). J. Jpn Pediatr. Soc. 112, 1748\u20131757 (2008). (Japanese)","journal-title":"J. Jpn Pediatr. Soc."},{"key":"1793_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/jdi.12810","volume":"9","author":"M Haneda","year":"2018","unstructured":"M. Haneda, M. Noda, H. Origasa, H. Noto, D. Yabe, Y. Fujita, A. Goto, T. Kondo, E. Araki, Japanese Clinical Practice Guideline for Diabetes 2016. J. Diabetes Investig. 9, 657\u2013697 (2018)","journal-title":"J. Diabetes Investig."},{"key":"1793_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1651-2227.1988.tb10698.x","volume":"77","author":"J Aman","year":"1988","unstructured":"J. Aman, L. Wranne, Hypoglycaemia in childhood diabetes. II. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Acta Paediatr. Scand. 77, 548\u2013553 (1988)","journal-title":"Acta Paediatr. Scand."},{"key":"1793_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2337\/diacare.24.4.643","volume":"24","author":"MW Haymond","year":"2001","unstructured":"M.W. Haymond, B. Schreiner, Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes. Diabetes Care 24, 643\u2013645 (2001)","journal-title":"Diabetes Care"},{"key":"1793_CR15","unstructured":"The Japan Diabetes Society, The Japanese Society for Pediatric Endocrinology, Pediatric and Adolescent Diabetes Consensus Guidelines, p. 262-167 (Nankodo, Tokyo 2015) (Japanese)"},{"key":"1793_CR16","unstructured":"The Japan Diabetes Society, Japanese Clinical Practice Guideline for Diabetes 2016, p. 449-472 (Nankodo, Tokyo 2016) (Japanese)"},{"key":"1793_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1932296814557518","volume":"9","author":"AE Pontiroli","year":"2015","unstructured":"A.E. Pontiroli, Intranasal glucagon: a promising approach for treatment of severe hypoglycemia. J. Diabetes Sci. Technol. 9, 38\u201343 (2015)","journal-title":"J. Diabetes Sci. Technol."},{"key":"1793_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dc17-1402","volume":"41","author":"U H\u00f6velmann","year":"2018","unstructured":"U. H\u00f6velmann, B.V. Bysted, U. Mouritzen, F. Macchi, D. Lamers, B. Kronshage, D.V. M\u00f8ller, T. Heise, Pharmacokinetic and pharmacodynamic characteristics of dasiglucagon, a novel soluble and stable glucagon analog. Diabetes Care 41, 531\u2013537 (2018)","journal-title":"Diabetes Care"},{"key":"1793_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","volume":"23","author":"DIAMOND Project Group","year":"2006","unstructured":"DIAMOND Project Group, Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet. Med. 23, 857\u2013866 (2006)","journal-title":"Diabet. Med."},{"key":"1793_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12020-015-0775-7","volume":"53","author":"A Coppola","year":"2016","unstructured":"A. Coppola, L. Sasso, A. Bagnasco, A. Giustina, C. Gazzarsuo, The role of patient education in the prevention and management of type 2 diabetes: an overview. Endocrine 53, 18\u201327 (2016)","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1793-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1793-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T20:44:18Z","timestamp":1572036258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1793-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1793"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1793-z","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"W.O. received a research grant and lecture fees from Novo Nordisk. Y.H. received lecture fees from Novo Nordisk. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the guidelines of the Declaration of Helsinki, and the study protocol was approved by the ethics committee of Kobe University Graduate School of Medicine (Approval No. 170120).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all the participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}